Safety and Efficacy of Celecoxib Versus Placebo in the Treatment of Knee Osteoarthritis in Patients Who Were Unresponsive to Naproxen and Ibuprofen
Clinical trial NCT00638807 · COMPLETED
Trial details
- NCT number
- NCT00638807
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Enrollment
- 388
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.